论文期刊

取消

高级检索

检索历史清除

首页> Expert review of respiratory medicine> New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17-20, 2021).

New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17-20, 2021).

导出 LinkOut

翻译打印收藏纠错

作者： Jennifer,Quint ^[1] ; Jukka,Montonen ^[2] ; Dave,Singh ^[3] ; Herbert,Wachtel ^[4] ; Sharon,Attick ^[5] ; Swetha,Palli ^[6] ; Monica,Frazer ^[7] ; Vincent,Willey ^[8] ; Glenn,Giessel ^[9]

作者单位： National Heart and Lung Institute, Imperial College London, London, UK. ^[1] Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany. ^[2] Medicines Evaluations Unit, University of Manchester, Manchester University Foundation Hospitals Trust, Manchester, UK. ^[3] Device Development, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany. ^[4] Clinical Development & Operations, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. ^[5] Health Economics and Outcomes Research, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. ^[6] Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA. ^[7] Scientific Affairs, HealthCore, Wilmington, DE, USA. ^[8] Pulmonary Associates of Richmond, Richmond, VA, USA. ^[9]

关键词 COPD digital health exacerbation inhaled corticosteroids inspiratory flow long-acting muscarinic antagonist long-actingβ2-agonists olodaterol tiotropium triple therapy

主题词投药, 吸入(Administration, Inhalation);肾上腺皮质激素类(Adrenal Cortex Hormones);肾上腺素能β-2受体激动剂(Adrenergic beta-2 Receptor Agonists);支气管扩张药(Bronchodilator Agents);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);毒蕈碱拮抗剂(Muscarinic Antagonists);疾病大流行(Pandemics);植物提取物(Plant Extracts);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive)

DOI 10.1080/17476348.2022.2056022

PMID 35325585

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Expert review of respiratory medicine

Expert review of respiratory medicine

2022年16卷4期

485-493页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷